Cargando…

Glatiramer Acetate Immunomodulation: Evidence of Neuroprotection and Cognitive Preservation

Novel, neuroprotective uses of Copaxone (generic name: glatiramer acetate—GA) are being examined, primarily in neurological conditions involving cognitive decline. GA is a well-studied synthetic copolymer that is FDA-approved for immune-based treatment of relapsing remitting multiple sclerosis (RRMS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kasindi, Arielle, Fuchs, Dieu-Trang, Koronyo, Yosef, Rentsendorj, Altan, Black, Keith L., Koronyo-Hamaoui, Maya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099707/ https://www.ncbi.nlm.nih.gov/pubmed/35563884 http://dx.doi.org/10.3390/cells11091578

Ejemplares similares

The effects of enhancing angiotensin converting enzyme in myelomonocytes on ameliorating Alzheimer’s-related disease and preserving cognition
por: Danziger, Ron, et al.
Publicado: (2023)

Retinal Vasculopathy in Alzheimer’s Disease
por: Shi, Haoshen, et al.
Publicado: (2021)

Alzheimer’s Retinopathy: Seeing Disease in the Eyes
por: Mirzaei, Nazanin, et al.
Publicado: (2020)

Effects of IL-34 on Macrophage Immunological Profile in Response to Alzheimer's-Related Aβ(42) Assemblies
por: Zuroff, Leah R., et al.
Publicado: (2020)

Retinal capillary degeneration and blood-retinal barrier disruption in murine models of Alzheimer’s disease
por: Shi, Haoshen, et al.
Publicado: (2020)

Label-free hyperspectral imaging and deep-learning prediction of retinal amyloid β-protein and phosphorylated tau
por: Du, Xiaoxi, et al.
Publicado: (2022)

Color and contrast vision in mouse models of aging and Alzheimer’s disease using a novel visual-stimuli four-arm maze
por: Vit, Jean-Philippe, et al.
Publicado: (2021)

Activated Bone Marrow-Derived Macrophages Eradicate Alzheimer's-Related Aβ(42) Oligomers and Protect Synapses
por: Li, Songlin, et al.
Publicado: (2020)

Ocular indicators of Alzheimer’s: exploring disease in the retina
por: Hart, Nadav J., et al.
Publicado: (2016)

Optical Coherence Tomography in Alzheimer’s Disease and Other Neurodegenerative Diseases
por: Doustar, Jonah, et al.
Publicado: (2017)

Osteopontin depletion in macrophages perturbs proteostasis via regulating UCHL1-UPS axis and mitochondria-mediated apoptosis
por: Rentsendorj, Altan, et al.
Publicado: (2023)

Parallels between retinal and brain pathology and response to immunotherapy in old, late‐stage Alzheimer's disease mouse models
por: Doustar, Jonah, et al.
Publicado: (2020)

Identification of early pericyte loss and vascular amyloidosis in Alzheimer’s disease retina
por: Shi, Haoshen, et al.
Publicado: (2020)

T-Lymphocyte Deficiency Exacerbates Behavioral Deficits in the 6-OHDA Unilateral Lesion Rat Model for Parkinson’s Disease
por: Wheeler, Christopher J, et al.
Publicado: (2014)

Clearance of cerebral Aβ in Alzheimer’s disease: reassessing the role of microglia and monocytes
por: Zuroff, Leah, et al.
Publicado: (2017)

Acute neuropathological consequences of short-term mechanical ventilation in wild-type and Alzheimer’s disease mice
por: Lahiri, Shouri, et al.
Publicado: (2019)

Regulating microglial miR-155 transcriptional phenotype alleviates Alzheimer’s-induced retinal vasculopathy by limiting Clec7a/Galectin-3(+) neurodegenerative microglia
por: Shi, Haoshen, et al.
Publicado: (2022)

Sectoral segmentation of retinal amyloid imaging in subjects with cognitive decline
por: Dumitrascu, Oana M., et al.
Publicado: (2020)

Neuroprotection with glatiramer acetate: evidence from the PreCISe trial
por: Arnold, Douglas L., et al.
Publicado: (2013)

Functional recreation of age-related CD8 T cells in young mice identifies drivers of aging- and human-specific tissue pathology
por: Panwar, Akanksha, et al.
Publicado: (2020)

Retinal pathological features and proteome signatures of Alzheimer’s disease
por: Koronyo, Yosef, et al.
Publicado: (2023)

Follow-on glatiramer acetate
por: Cohen, Jeffrey A., et al.
Publicado: (2018)

Signature Effects of Vector-Guided Systemic Nano Bioconjugate Delivery Across Blood-Brain Barrier of Normal, Alzheimer’s, and Tumor Mouse Models
por: Israel, Liron L., et al.
Publicado: (2022)

Neuroprotective Effect of Combination Therapy of Glatiramer Acetate and Epigallocatechin-3-Gallate in Neuroinflammation
por: Herges, Katja, et al.
Publicado: (2011)

Editorial: Role of Inflammation in Neurodegenerative Diseases
por: Koronyo-Hamaoui, Maya, et al.
Publicado: (2022)

Glatiramer acetate in the treatment of multiple sclerosis
por: Tselis, Alex, et al.
Publicado: (2007)

The potential neuroprotective effects of weekly treatment with glatiramer acetate in diabetic patients after panretinal photocoagulation
por: Mitne, Somaia, et al.
Publicado: (2011)

Retinal Venular Tortuosity Jointly with Retinal Amyloid Burden Correlates with Verbal Memory Loss: A Pilot Study
por: Dumitrascu, Oana M., et al.
Publicado: (2021)

Demonstration of Equivalence of Generic Glatiramer Acetate and Copaxone(®)
por: Lipsky, Peter, et al.
Publicado: (2021)

Cognitive impairment in an animal model of multiple sclerosis and its amelioration by glatiramer acetate
por: Aharoni, Rina, et al.
Publicado: (2019)

Abnormal Changes in NKT Cells, the IGF-1 Axis, and Liver Pathology in an Animal Model of ALS
por: Finkelstein, Arseny, et al.
Publicado: (2011)

Neuroprotective Effect of Glatiramer Acetate on Neurofilament Light Chain Leakage and Glutamate Excess in an Animal Model of Multiple Sclerosis
por: Aharoni, Rina, et al.
Publicado: (2021)

The role of glatiramer acetate in the early treatment of multiple sclerosis
por: Brandes, David W
Publicado: (2010)

Spasticity in multiple sclerosis and role of glatiramer acetate treatment
por: Meca-Lallana, Jose Eustasio, et al.
Publicado: (2015)

Glatiramer Acetate-associated Refractory Immune Thrombocytopenic Purpura
por: Sagy, Iftach, et al.
Publicado: (2016)

Physicochemical and Biological Examination of Two Glatiramer Acetate Products
por: Komlosh, Arthur, et al.
Publicado: (2019)

Bullous pemphigoid as an injection site reaction of glatiramer acetate
por: Baghbanian, Seyed Mohammad, et al.
Publicado: (2019)

An Immunomodulatory Peptide Dendrimer Inspired from Glatiramer Acetate
por: Erzina, Dina, et al.
Publicado: (2021)

Adherence to glatiramer acetate treatment for multiple sclerosis: the Brazilian experience
por: de Oliveira, Tatiana de Melo Gomes, et al.
Publicado: (2008)

Glatiramer acetate desensitisation in multiple sclerosis patients - the case report
por: Novotna, Bronislava, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_1kdpnfi3ja8tpidq5d2vis1k7o